Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Baker

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|July 26, 2016
Ipilimumab for relapse after allogeneic transplantationHolly Baker
The Lancet. Oncology|January 18, 2016
Second cancer risk for Hodgkin's lymphoma survivorsHolly Baker
The Lancet. Oncology|January 3, 2016
Familial risk in patients with carcinoma of unknown primaryHolly Baker
The Lancet. Oncology|October 13, 2015
Overtreatment in stage IV lung cancer in the USAHolly Baker
The Lancet. Oncology|September 29, 2015
Cancer Drugs Fund failed to collect patient outcomesHolly Baker
The Lancet. Gastroenterology & Hepatology|January 13, 2025
Research in BriefHolly Baker
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Research in BriefHolly Baker
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Research in BriefHolly Baker
The Lancet. Oncology|June 21, 2016
Extending aromatase inhibitor adjuvant therapy to 10 yearsHolly Baker
The Lancet. Oncology|October 21, 2015
Radiotherapy in the elderly and frail with glioblastomaHolly Baker
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|July 26, 2016
Ipilimumab for relapse after allogeneic transplantationHolly Baker
The Lancet. Oncology|January 18, 2016
Second cancer risk for Hodgkin's lymphoma survivorsHolly Baker
The Lancet. Oncology|January 3, 2016
Familial risk in patients with carcinoma of unknown primaryHolly Baker
The Lancet. Oncology|October 13, 2015
Overtreatment in stage IV lung cancer in the USAHolly Baker
The Lancet. Oncology|September 29, 2015
Cancer Drugs Fund failed to collect patient outcomesHolly Baker
The Lancet. Gastroenterology & Hepatology|January 13, 2025
Research in BriefHolly Baker
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Research in BriefHolly Baker
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Research in BriefHolly Baker
The Lancet. Oncology|June 21, 2016
Extending aromatase inhibitor adjuvant therapy to 10 yearsHolly Baker
The Lancet. Oncology|October 21, 2015
Radiotherapy in the elderly and frail with glioblastomaHolly Baker
Pageof 8